+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

From
Buprenorphine Patches Market - Global Forecast 2025-2030 - Product Thumbnail Image

Buprenorphine Patches Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
From
Painkillers For Dogs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Painkillers For Dogs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
Pain Management for Pets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Pain Management for Pets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Lidocaine Patch Market - Global Forecast to 2030 - Product Thumbnail Image

Lidocaine Patch Market - Global Forecast to 2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Lidocaine Hydrochloride Gel Market - Global Forecast 2025-2030 - Product Thumbnail Image

Lidocaine Hydrochloride Gel Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Non-Opioid Therapeutics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Non-Opioid Therapeutics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Pain Management Devices - A Global Market Overview - Product Thumbnail Image

Pain Management Devices - A Global Market Overview

  • Report
  • November 2024
  • 261 Pages
  • Global
From
Non-opioid Pain Patch - Global Strategic Business Report - Product Thumbnail Image

Non-opioid Pain Patch - Global Strategic Business Report

  • Report
  • November 2025
  • 194 Pages
  • Global
From
Capsaicin Pain Relief Patch Market Report 2025 - Product Thumbnail Image

Capsaicin Pain Relief Patch Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Non-Opioid Pain Treatment Market Report 2025 - Product Thumbnail Image

Non-Opioid Pain Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Opioids Market Report 2025 - Product Thumbnail Image

Opioids Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Synthetic Cannabinoids Market Report 2025 - Product Thumbnail Image

Synthetic Cannabinoids Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Oxycodone Drugs Market Report 2025 - Product Thumbnail Image

Oxycodone Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Prescription Pain Medication Market Report 2025 - Product Thumbnail Image

Prescription Pain Medication Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Pain Management Drugs Market Report 2025 - Product Thumbnail Image

Pain Management Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Non-Opioid Pain Patch Market Report 2025 - Product Thumbnail Image

Non-Opioid Pain Patch Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Chronic Pain Treatment Global Market Report 2025 - Product Thumbnail Image

Chronic Pain Treatment Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Pain Management Global Market Report 2025 - Product Thumbnail Image

Pain Management Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more